Technology Networks

What Menopause May Be Doing to the Brain

A University of Cambridge study using UK Biobank data found menopause is linked to reduced gray matter in brain regions ...
Seeking Alpha

Cingulate Receives Guidance from FDA on Path Forward for Anxiety Asset CTx-2103 (buspirone)

KANSAS CITY, Kan., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (CING) (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform ...
News Medical

Anxiety and negative emotions reduced by brain circuit that consciously slows breathing

Researchers at the Salk Institute have discovered a brain pathway that connects the frontal cortex to the brainstem, offering potential therapeutic targets for anxiety, panic, and PTSD. Study: A ...
Seeking Alpha

Cingulate Receives $3 Million Grant from Private Foundation to Accelerate Development of Anxiety Asset CTx-2103 (buspirone)

KANSAS CITY, Kan., April 09, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (CING) (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform ...
Nasdaq

Cingulate Inc. Provides Clinical Update on CTx-1301 Pre-NDA Meeting and Announces $3 Million Grant for CTx-2103 Development

Cingulate Inc. completes FDA Pre-NDA meeting for ADHD drug CTx-1301 and secures $3 million grant for anxiety treatment CTx-2103. Cingulate Inc. announced the successful completion of a Pre-NDA meeting ...
FOX40 News

Cingulate Receives $3 Million Grant from Private Foundation to Accelerate Development of Anxiety Asset CTx-2103 (buspirone)

CTx-2103 has the Potential to be the First, Once-Daily Formulation of Buspirone, one of the Most Widely Prescribed Agents in the $5.5 Billion U.S. Anxiety Market, and the $11.6 Billion Anxiety Market ...